Literature DB >> 20538716

Regulation of the beta1,4-Galactosyltransferase I promoter by E2F1.

Yuanyan Wei1, Fengbiao Zhou, Yuqing Ge, Hong Chen, Chunhong Cui, Dan Liu, Zhiyuan Yang, Guoqiang Wu, Jialin Shen, Jianxin Gu, Jianhai Jiang.   

Abstract

Cell surface carbohydrate chains are widely known to contribute to cell migration, recognition and proliferation. beta1,4-Galactosyltransferase I (beta1,4GalT I) transfers galactose to the terminal N-acetylglucosamine of complex-type N-glycan, and contributes to cell proliferation, differentiation and migration. Here, we identified beta1,4GalT I as a novel target gene of cell cycle regulator E2F1. E2F1 proteins interact with the promoter of the beta1,4GalT I gene in vivo, and E2F1 over-expression stimulates the activity of beta1,4GalT I promoter and the mRNA and protein expression of beta1,4GalT I, and augments the level of beta1, 4-galactosyltion. Site-specific mutagenesis revealed that this region which contains two E2F1 binding site (nt -215 to -207 and +1 to +6) is necessary for beta1,4GalT I activation by E2F1. Furthermore, down-regulation of beta1,4GalT I expression attenuates E2F1-induced DNA synthesis and cell cycle progression as well as the expression of cell-cycle regulator Cyclin D1. Thus, beta1,4GalT I is an important E2F1 target gene that is required for cell cycle progression in mammalian cells, which elicits a new mechanism of cell growth and a new mechanism of beta1,4GalT I transcription.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538716     DOI: 10.1093/jb/mvq061

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  4 in total

1.  Epigenetics of Immunoglobulin G Glycosylation.

Authors:  Marija Klasić; Vlatka Zoldoš
Journal:  Exp Suppl       Date:  2021

Review 2.  Convergence: Lactosylceramide-Centric Signaling Pathways Induce Inflammation, Oxidative Stress, and Other Phenotypic Outcomes.

Authors:  Subroto Chatterjee; Amrita Balram; Wendy Li
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

3.  Use of a glycolipid inhibitor to ameliorate renal cancer in a mouse model.

Authors:  Subroto Chatterjee; Nezar Alsaeedi; Jennifer Hou; Veera Venkata Ratnam Bandaru; Lan Wu; Marc K Halushka; Roberto Pili; Georges Ndikuyeze; Norman J Haughey
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

4.  β4GALT1 controls β1 integrin function to govern thrombopoiesis and hematopoietic stem cell homeostasis.

Authors:  Silvia Giannini; Melissa M Lee-Sundlov; Leonardo Rivadeneyra; Christian A Di Buduo; Robert Burns; Joseph T Lau; Hervé Falet; Alessandra Balduini; Karin M Hoffmeister
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.